Evidence map›Paper›PMID 32886856›Full record

ReviewChemMedChem2020

Advancements in the Development of Non-Nitrogen-Based Amphiphilic Antiseptics to Overcome Pathogenic Bacterial Resistance.

Robert G Carden, Kyle J Sommers, Cassandra L Schrank, Austin J Leitgeb, Javier A Feliciano, William M Wuest, Kevin P C Minbiole

Abstract readReview
In one paragraph

Review in ChemMedChem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Merging antimicrobial and visible emission properties within 1,3,4-trisubstituted-1,2,3-triazolium salts.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2022
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert G CardenDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA.
Kyle J SommersDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA.
Cassandra L SchrankDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA.
Austin J LeitgebDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA.
Javier A FelicianoDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA.
William M WuestDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA.
Kevin P C MinbioleDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA.ORCID 0000-0003-4263-9833

Funding

Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific InhibitorsR35GM119426 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI William M Wuest · 2016 to 2026
$4.8M
Antimicrobial Resistance and Therapeutic Discovery Training ProgramT32AI106699 · NIAID · EMORY UNIVERSITY · PI Graeme L Conn, Joanna B Goldberg · 2014 to 2026
$2.7M
NIAID NIH HHS T32 AI106699NIGMS NIH HHS R35 GM119426NIGMS NIH HHS R35 GM119426
6 · The paper itself

Abstract

The prevalence of quaternary ammonium compounds (QACs) as common disinfecting agents for the past century has led bacteria to develop resistance to such compounds. Given the alarming increase in resistant strains, new strategies are required to combat this rise in resistance. Recent efforts to probe and combat bacterial resistance have focused on studies of multiQACs. Relatively unexplored, however, have been changes to the primary atom bearing positive charge in these antiseptics. Here we review the current state of the field of both phosphonium and sulfonium amphiphilic antiseptics, both of which hold promise as novel means to address bacterial resistance.

Indexed as

Anti-Bacterial AgentsAnti-Infective Agents, LocalBacteriaDrug DevelopmentDrug Resistance, BacterialMicrobial Sensitivity TestsQuaternary Ammonium CompoundsSurface-Active AgentsAnti-Bacterial AgentsAnti-Infective Agents, LocalQuaternary Ammonium CompoundsSurface-Active AgentsantisepticsqacAQacRquaternary ammonium compoundsquaternary phosphonium compoundstrivalent sulfonium compounds

Identifiers

PMID32886856
PMCPMC8371456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.